Skip to content
Search for:
About
Science
Team
News
Careers
Contact
Search for:
About
Science
Team
News
Careers
Contact
About
Science
Team
News
Careers
Contact
Search for:
News
News
Epsilon0924
2022-05-11T21:40:55-07:00
Press Releases
Compelling Data in Breast Cancer Treatment with First-In-Class Cyclin A/B Inhibitor Presented at 2023 AACR-NCI-EORTC International Conference
23 October, 2023
Read More
Circle Pharma Announces Upcoming Presentation at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9 October, 2023
Read More
Circle Pharma strengthens its executive leadership team with two senior appointments in Clinical Development
26 July, 2023
Read More
Circle Pharma Achieves Major Milestone with the Selection of a Clinical Development Candidate Directly Inhibiting Cyclins A and B
19 July, 2023
Read More
Circle Pharma’s first-in-class orally bioavailable macrocyclic cyclin A/B inhibitors highlighted in poster presentations at American Association for Cancer Research Annual Meeting
19 April, 2023
Read More
Circle Pharma appoints Stephen Kelsey, MB ChB, MD, to its board of directors
15 December, 2022
Read More
Circle Pharma Appoints Paul Park, MBA, as its Chief Business Officer
26 July, 2022
Read More
Circle Pharma announces presentation at the American Association for Cancer Research 2022 Annual Meeting
11 April, 2022
Read More
Circle Pharma appoints Evelyn Wang, PhD as its Vice President, Translational Medicine
12 July, 2021
Read More
Circle Pharma raises $66 Million in Series C Financing
16 June, 2021
Read More
Circle Pharma appoints Constantine Kreatsoulas, PhD as its Vice President, Research Informatics and Computational Chemistry
1 February, 2021
Read More
Circle Pharma Appoints James Aggen, PhD as Its Vice President, Medicinal Chemistry
26 October, 2020
Read More
Circle Pharma Appoints Alan Ashworth, PhD, FRS and Bruce Stillman, PhD, FRS to Its SAB
21 October, 2020
Read More
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer
20 July, 2020
Read More
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board
27 May, 2020
Read More
Circle Pharma raises $45 Million in Series B Financing
17 March, 2020
Read More
Circle Pharma Congratulates Dr. William G. Kaelin, Jr., MD on Award of Nobel Prize
9 October, 2019
Read More
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.
17 January, 2018
Read More
Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer
20 November, 2017
Read More
Circle Pharma announces expansion of Series A financing and appointment of James C. Lu to its board
25 April, 2017
Read More
Circle Pharma announces Series A financing and appoints Walter H. Moos, Ph.D., to its board
21 December, 2016
Read More
Circle Pharma enters into an agreement with Pfizer to build screening library of macrocyclic peptides
12 September, 2016
Read More
Circle Pharma Announces Appointment of Co-Founder Prof. Matthew Jacobson to Department Chair
19 January, 2016
Read More
Circle Pharma Announces Receipt of Additional Seed Investment, and Relocation to New Laboratory Facility
7 January, 2016
Read More
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations
22 September, 2014
Read More
Page load link
Go to Top
